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Pondering on Pesticides
Long-Term Low Levels Impair Thinking
As Homer wrote, “Wine can of their wits the wise beguile,” but
what of the grapes that make the wine—or rather, the pesticides
with which they are treated? Isabelle Baldi of the Institut de Santé
Publique d’Epidémiologie et de Développement in Bordeaux,
France and colleagues went to their local vineyards to measure
workers’ cognitive well-being and see how it related to the amount
of pesticides they had encountered over the years [EHP
109:839–844]. Previous studies had shown that high-dose pesti-
cide poisoning can cause acute human health effects such as motor
skill damage, impaired intellectual functioning, and memory loss.
In this study, the first to assess long-term neuropsychologic effects
of chronic, low-level pesticide exposures in a large sample of work-
ers, Baldi and colleagues found many examples of impaired cogni-
tive functioning among exposed workers.
The team interviewed 917 men and women, aged 43–58,
between February 1997 and August 1998. Of the study participants,
528 had been directly exposed to pesticides through mixing or spray-
ing over a mean of 22 years, another 173 had been indirectly exposed
by contact with treated plants, and 216 had never been exposed. The
pesticides used were primarily fungicides. 
The team administered nine neuropsychologic tests to the work-
ers, including the Mini-Mental Status Examination (which measures
different cognitive components), the Wechsler Paired Associates Test
of memory, the Benton Visual Retention Test, the Isaacs Set Test
(which measures the ability to quickly generate lists of words in dif-
ferent semantic categories), and the Finger Tapping Test (which
assesses motor speed). The team controlled for factors that could alter
test scores, including educational level, age, sex, alcohol consump-
tion, smoking, environmental exposures, and depressive symptoms.
Workers who were either directly or indirectly exposed performed
worse on tests of memory, selective attention, verbal fluency, and
abstraction compared with nonexposed workers. On a test of both
selective attention and working memory, directly exposed workers
were 3.5 times more likely to score low compared with nonexposed
subjects. On a similar test of selective attention and mental flexibility,
the exposed individuals were 3.1 times more likely to score low. The
exposed men and women processed information less quickly than
nonexposed colleagues, although performances of exposed workers
were similar to those of the nonexposed if the tasks were slowed. 
The study participants’ symptoms were subclinical and didn’t
appear to interfere with their work, the team writes, and the partici-
pants didn’t complain about their cognitive deficits. But they might
run into cognitive problems as they age, Baldi notes. “This is why we
planned a four-year follow-up of the population [starting in 2001] to
assess evolution of performances,” she says.
One surprising finding: although large amounts of alcohol are
neurotoxic, the workers who drank moderately had better test scores
than nondrinkers. Other studies have shown a protective effect of
moderate wine consumption on cognitive performance. Baldi can’t
explain the finding, but notes that among these workers alcohol is
considered “a noble product.” –Tina Adler
Lead in Your Body
Genotype Determines What Stays, What Goes
The same lead exposure can cause widely varying symptoms of lead
intoxication and levels of organ dysfunction in different people.
According to Howard Hu of Harvard University and his colleagues,
an underlying cause may be genetic polymorphism in the δ -amino-
levulinic acid dehydratase (ALAD) gene [EHP 109:827–832].
The team studied ALAD polymorphism and its relation to altered
concentrations of bone and blood lead among 726 middle-aged and
elderly men who had been exposed to lead nonoccupationally. Given
their ages, these men would have faced now-obsolete lead exposures
such as inhaling combusted leaded gasoline and ingesting food from
lead-soldered cans, as well as still-present exposures such as eating veg-
etables grown in lead-contaminated soil. The men were participants in
the Normative Aging Study, a longitudinal study of aging begun in
1963. Middle-aged to elderly men are at the highest risk for the onset
of certain chronic diseases such as hypertension, stroke, heart attack,
and dementia, and Hu and colleagues believe that cumulative lead
exposure may be a signifant risk factor for these problems.
Bone lead measurements were taken at the thigh and the knee.
These sites were chosen because they consist, respectively, of pure
cortical and pure trabecular bone. Cortical bone has very slow
turnover; lead that is deposited there persists for many decades and
thus provides a good reflection of total lead exposure. Conversely,
trabecular bone has a relatively rapid turnover and releases a good
deal of lead into the blood. Trabecular bone is therefore a good
reflection of bone lead stores that can be mobilized into circulation. 
The results showed that patella lead was the major predictor of
blood lead in this aging nonoccupationally exposed population and
that ALAD polymorphism significantly affected this association. For
example, when patella lead exceeded 60 µg/g, blood lead concentra-
tions in carriers of the ALAD 2 allele were higher than those in ALAD
1-1 carriers. By contrast, when patella lead concentrations were lower
than 40 µg/g, blood lead concentrations were higher in ALAD 1-1
carriers than in ALAD 2 carriers. On the basis of their results, Hu and
his colleagues suggest that when blood lead concentrations are rela-
tively low—less than about 8 µg/dL, for instance—ALAD 1-1 carriers
will have higher blood lead concentrations than ALAD 2 carriers. 
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Lost in thought among the vines. A study conducted on vineyard
workers showed for the first time that long-term low-level exposures to
pesticides have measurable effects on cognition.Some earlier studies on ALAD polymorphism and blood lead
found that individuals with the ALAD 2 allele had higher blood
lead concentrations. Others did not find this relationship. The
results of Hu’s study suggest a possible reason for this discrepancy:
the relationship between the ALAD polymorphism and blood lead
may actually depend on how much lead is in bone, a parameter that
had not been previously measured in most ALAD polymorphism
studies. Hu and colleagues caution, however, that this finding is
tentative and needs to be verified in other community-exposed pop-
ulation studies.
ALAD polymorphism, then, might modify the exchange of lead
between blood and bone, which in turn could modify a person’s
risk for lead toxicity. Several previous studies have indeed found
that ALAD polymorphism modifies certain symptoms of lead
intoxication, such as impaired kidney, reproductive, and neuro-
psychological function. For instance, one study found the ALAD 2
allele to correlate with impaired kidney function, yet other studies
found this same allele to be protective of neuropsychological and
male reproductive function. More research is needed for a precise
definition of the mechanism of function and of the potential
impact of ALAD polymorphism on lead kinetics and toxicity. 
–Julian Josephson
Mice Beat Rats
The Best Model for Testing Endocrine Disruptors
Endocrine disruptors, or chemicals that interfere with hormone
activity, abound in our environment. They are found in such syn-
thetics as pesticides, preservatives, paints, and plastics, as well as in
natural sources such as soy products. To date, approximately 50
chemicals have been identified as endocrine disruptors. However, in
the United States alone there are more than 80,000 chemicals now
in commercial use that have not yet been test-
ed for such effects. A 1998 U.S. Environ-
mental Protection Agency report called for
testing of all environmental chemicals for
their estrogenic effects and recommended
using an in vivo screen measuring uterine
growth in rodents. In this issue, Elizabeth
Padilla-Banks, Wendy N. Jefferson, and
Retha R. Newbold, all of the NIEHS, com-
pare the sensitivity of mice versus rats as a
model for the testing of estrogenic effects of
endocrine disruptors [EHP 109:821–826].
In humans, exposure to endocrine disrup-
tors has been proposed to be linked to repro-
ductive and developmental abnormalities,
increases in hormone-related cancers, attention
deficit/hyperactivity disorder, and behavioral
problems. Animals are particularly sensitive to
effects from exposure to endocrine disruptors,
and as such make good models for testing.
Rats are most commonly used in toxicity
testing, but they are more expensive to use than
mice—nearly twice as expensive to purchase
and three times as expensive to house. Rats can
have other disadvantages as well; they are more
variable in factors such as body size and uterine
response, so more of them must be tested to
pick up subtle differences. 
In their study, the researchers compared the
sensitivity of the immature CD-1 mouse to that
of the immature Sprague-Dawley rat. Each species was exposed to vary-
ing doses of the female sex hormone 17β -estradiol and compared to an
unexposed cohort. After three days of exposure, the animals were sacri-
ficed and their uterine weight:body weight ratios determined. The
researchers measured uterine epithelial cell height and number, as well
as gland number, all of which increase with estrogenic activity and are
therefore useful markers for testing chemicals with unknown estro-
genicity. They also measured expression of the estrogen-inducible pro-
teins lactoferrin and complement C3.
In general, the rats and mice proved to be equally well suited for
uterotropic bioassay. Both species showed a similar dose–response
increase in uterine wet weight as a result of exposure to 17β -estradiol,
although mice were more sensitive than rats at all doses tested.
(Uterine wet weight, which includes both the tissue and fluid content
of the uterus, is a more meaningful measure than dry weight because
estrogens increase water absorption and the amount of fluid in the
uterine cavity.) Both species showed an increase in uterine epithelial
cell height over their respective controls. With respect to epithelial
cell number, mice showed a greater increase than rats at any given
dose. Further, mice showed an increase in gland number, while rats
did not. Both rats and mice showed strong expression of lactoferrin
and complement C3 in the uterine epithelial cells following 17β -
estradiol treatment. 
Over the course of testing, researchers found a significantly greater
variation in body weight in the rats versus the mice. Such variability in
an experiment can decrease the significance of the results, such that
weak estrogens may not be detected. The lower the variability, the
fewer animals need to be used for testing. Thus, the ability to use mice
might potentially translate into lower animal husbandry costs.
Further, the smaller size of the mouse would mean that lesser amounts
of chemical compounds would be required for testing. “The bottom
line is that we can test more chemicals more efficiently using the
mouse model versus the rat model,” says Newbold. –John S. Manuel
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Murine supermodel? A comparative analysis shows that mice should provide a more accurate
and less expensive model for testing endocrine disruptors than the traditionally used rats.